000			01791 a2200493 4500
005			20250514161413.0
264		0	_c20031201
008			200312s 0 0 eng d
022			_a0077-8923
024	7		_a10.1196/annals.1254.061 _2doi
040			_aNLM _beng _cNLM
100	1		_aWolfe, Gil I
245	0	0	_aDevelopment of a thymectomy trial in nonthymomatous myasthenia gravis patients receiving immunosuppressive therapy. _h[electronic resource]
260			_bAnnals of the New York Academy of Sciences _cSep 2003
300			_a473-80 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdrenal Cortex Hormones _xtherapeutic use
650	0	4	_aAdult
650	0	4	_aAge of Onset
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aHumans
650	0	4	_aImmunosuppression Therapy _xmethods
650	0	4	_aImmunosuppressive Agents
650	0	4	_aMiddle Aged
650	0	4	_aMyasthenia Gravis _xblood
650	0	4	_aPatient Selection
650	0	4	_aPrognosis
650	0	4	_aReceptors, Cholinergic _ximmunology
650	0	4	_aRetrospective Studies
650	0	4	_aSeverity of Illness Index
650	0	4	_aSingle-Blind Method
650	0	4	_aThymectomy _xmethods
650	0	4	_aThymoma _xblood
650	0	4	_aThymus Neoplasms _xblood
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aKaminski, Henry J
700	1		_aJaretzki, Alfred
700	1		_aSwan, Anthony
700	1		_aNewsom-Davis, John
773	0		_tAnnals of the New York Academy of Sciences _gvol. 998 _gp. 473-80
856	4	0	_uhttps://doi.org/10.1196/annals.1254.061 _zAvailable from publisher's website
999			_c14331112 _d14331112